Skip to main content

OTCMKTS:VBIZF - Viva Biotech Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.97
+0.30 (1.20%)
1 month | 3 months | 12 months
Get New Viva Biotech Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VBIZF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VBIZF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Viva Biotech in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.97.

Hold

The current consensus among 1 polled investment analysts is to hold stock in Viva Biotech.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/16/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/14/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/14/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/12/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/10/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/9/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/21/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
i
(Data available from 5/9/2016 forward)
Viva Biotech logo
Viva Biotech Holdings provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company develops structure based drug discovery, fragment based drug discovery, affinity selection mass spectrometry screening, and membrane protein targeted drug discovery platforms. The company's products include cell lines, crystal structures, GPCR proteins, antibodies, and proteins. It also offers EFS, gene-to-protein and gene-to-structure, viva engine for lead discovery, medicinal chemistry, in vitro pharmacology, and antibody discovery services. Viva Biotech Holdings was founded in 2008 and is headquartered in Shanghai, China.
Read More

Today's Range

Now: $0.97
$0.97
$0.97

50 Day Range

MA: $0.63
$0.50
$1.00

52 Week Range

Now: $0.97
$0.00
$1.80

Volume

N/A

Average Volume

5,225 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Viva Biotech?

The following Wall Street analysts have issued stock ratings on Viva Biotech in the last twelve months: JPMorgan Chase & Co..
View the latest analyst ratings for VBIZF.

What is the current price target for Viva Biotech?

0 Wall Street analysts have set twelve-month price targets for Viva Biotech in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Viva Biotech in the next year.
View the latest price targets for VBIZF.

What is the current consensus analyst rating for Viva Biotech?

Viva Biotech currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in VBIZF, but not buy more shares or sell existing shares.
View the latest ratings for VBIZF.

What other companies compete with Viva Biotech?

How do I contact Viva Biotech's investor relations team?

The company's listed phone number is 86 21 6089 3288. The official website for Viva Biotech is www.vivabiotech.com.cn.